Abstract
One hundred seven men with Haemophilus ducreyi-positive chancroid were assigned to receive 300 mg of rosoxacin as a single dose or 150 mg twice daily for 3 days. Ulcers and buboes were followed clinically and bacteriologically for 1 month. Of 40 evaluable males on the 3-day regimen, 38 (95%) were cured, while only 14 of 23 (61%) males on the single-dose regimen were cured; this regimen was discontinued. There was one ulcer relapse at day 21 in both groups; the one relapse in the single-dose group had a persistent culture-positive bubo. Eight of nine (89%) buboes followed to the endpoint on the 3-day rosoxacin regimen were cured, versus three of six (50%) on the single-dose regimen. Adverse effects were mainly related to the central nervous system but were minor and did not require intervention. None of the treatment failures was due to organisms resistant to rosoxacin, and failure of the single-dose regimen presumably was related to duration of tissue levels rather than to drug resistance. Administration of 150 mg of rosoxacin twice daily for 3 days is an effective regimen for the therapy of chancroid and is a reasonable alternative to other short-course regimens.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Albritton W. L., Brunton J. L., Slaney L., MacLean I. Plasmid-mediated sulfonamide resistance in Haemophilus ducreyi. Antimicrob Agents Chemother. 1982 Jan;21(1):159–165. doi: 10.1128/aac.21.1.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Calubiran O. V., Crisologo-Vizconde L. B., Tupasi T. E., Torres C. A., Limson B. M. Treatment of uncomplicated gonorrhoea in women. Comparison of rosoxacin and spectinomycin. Br J Vener Dis. 1982 Aug;58(4):231–235. doi: 10.1136/sti.58.4.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cohen A. I., Rein M. F., Noble R. C. A comparison of rosoxacin with ampicillin and probenecid in the treatment of uncomplicated gonorrhea. Sex Transm Dis. 1984 Jan-Mar;11(1):24–27. doi: 10.1097/00007435-198401000-00005. [DOI] [PubMed] [Google Scholar]
- Fast M. V., Nsanze H., D'Costa L. J., Karasira P., Maclean I. W., Piot P., Albritton W. L., Ronald A. R. Antimicrobial therapy of chancroid: an evaluation of five treatment regimens correlated with in vitro sensitivity. Sex Transm Dis. 1983 Jan-Mar;10(1):1–6. [PubMed] [Google Scholar]
- Handsfield H. H., Judson F. N., Holmes K. K. Treatment of uncomplicated gonorrhea with rosoxacin. Antimicrob Agents Chemother. 1981 Nov;20(5):625–629. doi: 10.1128/aac.20.5.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Latif A. S. Thiamphenicol in the treatment of chancroid in men. Br J Vener Dis. 1982 Feb;58(1):54–55. doi: 10.1136/sti.58.1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nsanze H., Fast M. V., D'Costa L. J., Tukei P., Curran J., Ronald A. Genital ulcers in Kenya. Clinical and laboratory study. Br J Vener Dis. 1981 Dec;57(6):378–381. doi: 10.1136/sti.57.6.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Plummer F. A., D'Costa L. J., Nsanze H., Maclean I. W., Karasira P., Piot P., Fast M. V., Ronald A. R. Antimicrobial therapy of chancroid: effectiveness of erythromycin. J Infect Dis. 1983 Oct;148(4):726–731. doi: 10.1093/infdis/148.4.726. [DOI] [PubMed] [Google Scholar]
- Plummer F. A., Maggwa N., D'Costa L. J., Nsanze H., Karasira P., Maclean I. W., Ronald A. R. Cefotaxime treatment of Haemophilus ducreyi infection in Kenya. Sex Transm Dis. 1984 Oct-Dec;11(4):304–307. doi: 10.1097/00007435-198410000-00008. [DOI] [PubMed] [Google Scholar]
- Plummer F. A., Nsanze H., D'Costa L. J., Karasira P., Maclean I. W., Ellison R. H., Ronald A. R. Single-dose therapy of chancroid with trimethoprim-sulfametrole. N Engl J Med. 1983 Jul 14;309(2):67–71. doi: 10.1056/NEJM198307143090202. [DOI] [PubMed] [Google Scholar]
- Plummer F. A., Nsanze H., D'Costa L. J., Ndugga Maggwa A. B., Girouard Y., Karasira P., Albritton W. L., Ronald A. R. Short-course and single-dose antimicrobial therapy for chancroid in Kenya: studies with rifampin alone and in combination with trimethoprim. Rev Infect Dis. 1983 Jul-Aug;5 (Suppl 3):S565–S572. doi: 10.1093/clinids/5.supplement_3.s565. [DOI] [PubMed] [Google Scholar]
- Romanowski B., Austin T. W., Pattison F. L., Lawee D., Portnoy D., Givan K. F., Li E. L., Nguyen K. B. Rosoxacin in the therapy of uncomplicated gonorrhea. Antimicrob Agents Chemother. 1984 Apr;25(4):455–457. doi: 10.1128/aac.25.4.455. [DOI] [PMC free article] [PubMed] [Google Scholar]